INCY
Incyte Corporation
$70.39
Earnings Summary
Revenue | $1137.87Mn |
Net Profits | $106.46Mn |
Net Profit Margins | 9.36% |
Highlights
Incyte Corporation’s revenue jumped 23.81% since last year same period to $1137.87Mn in the Q3 2024. On a quarterly growth basis, Incyte Corporation has generated 9.02% jump in its revenue since last 3-months.
Incyte Corporation’s net profit fell -37.84% since last year same period to $106.46Mn in the Q3 2024. On a quarterly growth basis, Incyte Corporation has generated 123.94% jump in its net profits since last 3-months.
Incyte Corporation’s net profit margin fell -49.8% since last year same period to 9.36% in the Q3 2024. On a quarterly growth basis, Incyte Corporation has generated 121.96% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Incyte Corporation post its latest quarter earnings
EPS Estimate Current Year | 0.84 |
Highlights
Incyte Corporation’s earning per share (EPS) estimates for the current year stand at 0.84.
Key Ratios
Key ratios of the Incyte Corporation post its Q3 2024 earnings
Earning Per Share (EPS) | 1.07 |
Highlights
Incyte Corporation’s earning per share (EPS) fell -2.73% since last year same period to 1.07 in the Q3 2024. This indicates that the Incyte Corporation has generated -2.73% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-04-30 | 0.84 | 0.64 | -23.81% |
2024-10-29 | 1.07 | 1.07 | 0% |
2024-07-30 | -1.55 | -1.82 | -17.42% |
₹0 US Stocks a/c Opening Fee